Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Trung Huynh is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/28/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | INSM | Buy Now | Insmed | $77.01 | 42.84% | Trung Huynh69% | $105 → $110 | Maintains | Buy | Get Alert |
| 02/13/2025 | JSPR | Buy Now | Jasper Therapeutics | $4.84 | 685.12% | Trung Huynh69% | → $38 | Initiates | → Buy | Get Alert |
| 02/13/2025 | CLDX | Buy Now | Celldex Therapeutics | $19.98 | 120.22% | Trung Huynh69% | → $44 | Initiates | → Buy | Get Alert |
| 01/16/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $635.83 | 16.07% | Trung Huynh69% | $1130 → $738 | Downgrade | Buy → Neutral | Get Alert |
| 10/10/2024 | KYTX | Buy Now | Kyverna Therapeutics | $2.37 | 448.52% | Trung Huynh69% | → $13 | Initiates | → Buy | Get Alert |
| 10/10/2024 | CABA | Buy Now | Cabaletta Bio | $1.57 | 536.9% | Trung Huynh69% | → $10 | Initiates | → Buy | Get Alert |
| 10/09/2024 | BMY | Buy Now | Bristol-Myers Squibb | $58.97 | -8.43% | Trung Huynh69% | $50 → $54 | Maintains | Neutral | Get Alert |
| 08/09/2024 | INSM | Buy Now | Insmed | $77.01 | 9.08% | Trung Huynh69% | $78 → $84 | Maintains | Buy | Get Alert |
| 05/29/2024 | INSM | Buy Now | Insmed | $77.01 | -24.69% | Trung Huynh69% | $46 → $58 | Maintains | Buy | Get Alert |
| 02/27/2024 | INSM | Buy Now | Insmed | $77.01 | -40.27% | Trung Huynh69% | → $46 | Initiates | → Buy | Get Alert |
| 10/20/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.97 | 1.75% | Trung Huynh69% | $70 → $60 | Assumes | Neutral → Neutral | Get Alert |
| 10/20/2023 | LLY | Buy Now | Eli Lilly | $822.00 | -13.63% | Trung Huynh69% | $612 → $710 | Assumes | Buy → Buy | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $822.00 | -29.44% | Trung Huynh69% | $490 → $580 | Maintains | Outperform | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $822.00 | -29.44% | Trung Huynh69% | $490 → $580 | Maintains | Outperform | Get Alert |
| 07/21/2023 | JNJ | Buy Now | Johnson & Johnson | $163.20 | 7.23% | Trung Huynh69% | $170 → $175 | Maintains | Neutral | Get Alert |
| 07/12/2023 | AMGN | Buy Now | Amgen | $304.52 | -34.32% | Trung Huynh69% | $220 → $200 | Maintains | Outperform | Get Alert |
| 06/29/2023 | PFE | Buy Now | Pfizer | $25.01 | 59.94% | Trung Huynh69% | $47 → $40 | Downgrade | Outperform → Neutral | Get Alert |
| 05/04/2023 | LLY | Buy Now | Eli Lilly | $822.00 | -40.39% | Trung Huynh69% | $420 → $490 | Maintains | Outperform | Get Alert |
| 05/03/2023 | PFE | Buy Now | Pfizer | $25.01 | 87.92% | Trung Huynh69% | $50 → $47 | Maintains | Outperform | Get Alert |
| 04/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.97 | 22.1% | Trung Huynh69% | $78 → $72 | Maintains | Neutral | Get Alert |
| 04/28/2023 | LLY | Buy Now | Eli Lilly | $822.00 | -48.91% | Trung Huynh69% | $400 → $420 | Maintains | Outperform | Get Alert |
| 03/07/2023 | MRK | Buy Now | Merck & Co | $87.95 | 43.26% | Trung Huynh69% | $125 → $126 | Maintains | Outperform | Get Alert |
| 02/13/2023 | MRK | Buy Now | Merck & Co | $87.95 | 42.13% | Trung Huynh69% | $120 → $125 | Maintains | Outperform | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $304.52 | -27.76% | Trung Huynh69% | $240 → $220 | Maintains | Underperform | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $25.01 | 99.92% | Trung Huynh69% | $54 → $50 | Maintains | Outperform | Get Alert |
| 12/06/2022 | LLY | Buy Now | Eli Lilly | $822.00 | -51.34% | Trung Huynh69% | $395 → $400 | Maintains | Outperform | Get Alert |
| 11/18/2022 | LLY | Buy Now | Eli Lilly | $822.00 | -51.95% | Trung Huynh69% | → $395 | Initiates | → Outperform | Get Alert |
| 11/18/2022 | JNJ | Buy Now | Johnson & Johnson | $163.20 | 4.17% | Trung Huynh69% | → $170 | Initiates | → Neutral | Get Alert |
| 11/18/2022 | PFE | Buy Now | Pfizer | $25.01 | 119.91% | Trung Huynh69% | → $55 | Initiates | → Outperform | Get Alert |
| 11/18/2022 | ABBV | Buy Now | AbbVie | $202.73 | -16.14% | Trung Huynh69% | → $170 | Initiates | → Outperform | Get Alert |
| 11/18/2022 | BMY | Buy Now | Bristol-Myers Squibb | $58.97 | 32.27% | Trung Huynh69% | → $78 | Initiates | → Neutral | Get Alert |
| 11/18/2022 | AMGN | Buy Now | Amgen | $304.52 | -21.19% | Trung Huynh69% | → $240 | Initiates | → Underperform | Get Alert |
| 11/18/2022 | MRK | Buy Now | Merck & Co | $87.95 | 36.44% | Trung Huynh69% | → $120 | Initiates | → Outperform | Get Alert |
| 03/23/2021 | GRFS | Buy Now | Grifols | $7.18 | — | Trung Huynh69% | — | Upgrade | Neutral → Outperform | Get Alert |
